A 10-Year Survey of Antifungal Susceptibility of Candidemia Isolates from Intensive Care Unit Patients in Greece

被引：23
|
作者：
Dimopoulos, George [1 ,2 ]
Velegraki, Aristea [3 ]
Falagas, Matthew E. [2 ,4 ]
机构：
[1] Univ Athens, Sch Med, Univ Hosp Attikon, Dept Crit Care, Athens 11528, Greece
[2] Alfa Inst Biomed Sci, Athens, Greece
[3] Univ Athens, Sch Med, Mycol Lab, Athens 11528, Greece
[4] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2009年 / 53卷 / 03期
关键词：
BLOOD-STREAM INFECTIONS; EUROPEAN COMMITTEE; RISK-FACTORS; VORICONAZOLE; CASPOFUNGIN; FLUCONAZOLE; MORTALITY; STANDARD; YEASTS; AGENTS;
D O I：
10.1128/AAC.01368-08
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
This study retrospectively reviews the susceptibility of 135 baseline ICU candidemia isolates (from 1997 to 2007) to nine antifungals as determined by the AFST-EUCAST microdilution method and identifies the most frequent causative agents of confirmed point-source candidemia outbreaks in local intensive care units. A minority of common and rare Candida species displayed decreased susceptibility to all antifungals.
引用
收藏
页码：1242 / 1244
页数：3
相关论文
共 50 条
  • [41] Epidemiological Trends of Fungemia in Greece with a Focus on Candidemia during the Recent Financial Crisis: a 10-Year Survey in a Tertiary Care Academic Hospital and Review of Literature
    Siopi, Maria
    Tarpatzi, Aikaterini
    Kalogeropoulou, Eleni
    Damianidou, Sofia
    Vasilakopoulou, Alexandra
    Vourli, Sophia
    Pournaras, Spyros
    Meletiadis, Joseph
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (03)
  • [42] Late Intensive Care Unit Admission in Liver Transplant Recipients: 10-Year Experience
    Atar, Funda
    Gedik, Ender
    Kaplan, Serife
    Zeyneloglu, Pinar
    Pirat, Arash
    Haberal, Mehmet
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2015, 13 : 15 - 21
  • [43] A 10-year retrospective audit of plasma exchange (PE) in the intensive care unit (ICU)
    Paton, E.
    Baldwin, I.
    AUSTRALIAN CRITICAL CARE, 2014, 27 (01) : 59 - 59
  • [44] ADMISSIONS TO A PEDIATRIC INTENSIVE-CARE UNIT FOR STATUS EPILEPTICUS - A 10-YEAR EXPERIENCE
    LACROIX, J
    DEAL, C
    GAUTHIER, M
    ROUSSEAU, E
    FARRELL, CA
    CRITICAL CARE MEDICINE, 1994, 22 (05) : 827 - 832
  • [45] Candidemia in pediatric patients in a German tertiary-care university hospital: A 10-year study
    Tragiannidis, A.
    Fegeler, W.
    Debus, V.
    Rellensmann, G.
    Mueller, V.
    Groll, A. H.
    MYCOSES, 2011, 54 (05) : 376 - 376
  • [46] Candidemia in the pediatric intensive care unit: What's different from candidemia in adults?
    Dotis J.
    Roilides E.
    Current Fungal Infection Reports, 2011, 5 (1) : 49 - 55
  • [47] Study of magnitude and risk factors in patients with candidemia at a tertiary care hospital with speciation and antifungal susceptibility of pathogenic Candida isolates
    Chauhan, Bhavana
    Kumar, Chaya Ashok
    Baveja, Sujata
    MEDICAL MYCOLOGY, 2022, 60 (SUPP 1) : 53 - 53
  • [48] Molecular Epidemiology and Antifungal Susceptibility of Candida Species Isolated from Urine Samples of Patients in Intensive Care Unit
    Yuksekkaya, Serife
    Findik, Duygu
    Arslan, Ugur
    MIKROBIYOLOJI BULTENI, 2011, 45 (01): : 137 - 149
  • [49] Cost-of-illness analysis of Candidemia in patients on the intensive care unit
    Heimann, S.
    Cornely, O. A.
    Wisplinghoff, H.
    Vehreschild, M. J. G. T.
    Franke, B.
    Glossmann, J.
    Vehreschild, J. J.
    MYCOSES, 2012, 55 : 325 - 326
  • [50] Anidulafungin for candidemia/invasive candidiasis in elderly intensive care unit patients
    Dimopoulos, G.
    Paiva, J. A.
    Meersseman, W.
    Pachl, J.
    Grigoras, I.
    Sganga, G.
    Menichetti, F.
    Montravers, P.
    Auzinger, G.
    Borges Sa, M.
    Miller, P.
    Marcek, T.
    Kantecki, M.
    Ruhnke, M.
    MYCOSES, 2011, 54 : 120 - 121
12345